Hjem › Atopisk dermatitis (eczem) › Ohio
Atopisk dermatitis (eczem) kliniske forsøg i Ohio
10 studier for Atopisk dermatitis (eczem) søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Dermatology Associates of Mid-Ohio- Site Number : 8400026, Marion
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050, Mason
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07290803Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Canton
- Enveda Investigative Site, Mayfield Heights
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Apex Clinical Research Center, LLC., Mayfield Heights
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 25. sep. 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Boardman
- Investigational Site, Mason
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07003425A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ClinOhio Research Services, Columbus
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 9, Columbus
- Inmagene Site 5, Mayfield Heights
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- DOCS Clinical Research - Canal Winchester /ID# 268271, Canal Winchester
- Wright State Physicians Health Center /ID# 268841, Fairborn
RekruttererFase 3
Alder 2 til 11 · Alle køn · Opdateret 6. aug. 2026 · NCT06461897Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
RekruttererFase 1
Alder 6 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Apex Clinical Research Center, Mayfield Heights
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7081, Dayton
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT06988605Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.